Work

Étude de pratique : tryptasémie au CHU Grenoble Alpes et indications recommandées

Year: 2024
Type: dissertation
Study design: Observational Study
Abstract: Introduction: Tryptase is a serine protease mainly synthesized by mast cells. Tryptasemia reflects the copie number of the TPSAB1 alphatryptase gene, the number of mast cells in the tissues and their activation. The tryptase assay is used in the context of anaphylaxis as well as for the detection, diagnosis and monitoring of mast cell pathologies. Tryptase dosing recommendations are well-defined. The objective of this study is to assess whether the tryptase assay is performed according to the recommended indications at the Grenoble Alpes University Hospital. Material and methods: This is a retrospective descriptive monocentric study of tryptases dosed at the University Hospital of Grenoble Alpes between January and March 2022. The dosage should have been prescribed by a physician from the Grenoble Alpes University Hospital during a consultation or hospitalization in one of its establishments. We provided a description of the clinical situations that led to their prescription for each dosage. Results: We have included 321 dosages. Only sixty-eight percent of the dosages were found to comply with the recommended indications. The main deviations from the recommendations concerned the temporality of the dosage in anaphylaxis and the tryptase dosage in the assessment of isolated spontaneous chronic urticaria. In addition, 24 assays were performed as part of the assessment of chronic digestive disorders. Discussion: The diagnosis of mast cell degranulation requires tryptase determination within the recommended time frame, but we have observed deviations that could potentially compromise the diagnosis of anaphylaxis. We also raised the question of the relevance of tryptase dosage in the assessment of chronic digestive disorders. Moreover, our results highlight the variety of clinical situations in which tryptase assay can be useful (mastocytosis, mast cell activation syndrome, hereditary alphatryptasemia, hypereosinophilia assessment). Conclusion: There are areas where tryptase dosing can be improved. This includes not only its use in the context of anaphylaxis, but also in the monitoring and screening of mast cell pathologies. Therefore, this work provides a chance to enhance our clinical practices by educating prescribers about recommendations.
Source: HAL
Author: Gendron, Sonia
Language: English
Subfield: Immunology
Open Access status: green
OpenAlex ID: W7028404662
Cites: 35
Cited by:
Related to: 10